Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Sakyo-ku, Kyoto, Japan.
Center for Genomic Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Eur J Hum Genet. 2021 Aug;29(8):1282-1291. doi: 10.1038/s41431-021-00854-5. Epub 2021 Apr 9.
While the advent of GWAS more than a decade ago has ushered in remarkable advances in our understanding of complex traits, the limitations of single-SNP analysis have also led to the development of several other approaches. Simulation studies have shown that the regional heritability mapping (RHM) method, which makes use of multiple adjacent SNPs jointly to estimate the genetic effect of a given region of the genome, generally has higher detection power than single-SNP GWAS. However, thus far its use has been mostly limited to agricultural settings, and its potential for the discovery of new genes in human diseases is yet to be fully exploited. In this study, by applying the RHM method to primary biliary cholangitis (PBC) in the Japanese population, we identified three novel loci (STAT4, ULK4, and KCNH5) at the genome-wide significance level, two of which (ULK4 and KCNH5) have not been found associated with PBC in any population previously. Notably, these genes could not be detected by using conventional single-SNP GWAS, highlighting the potential of the RHM method for the detection of new susceptibility loci in human diseases. These findings thereby provide strong empirical evidence that RHM is an effective and practical complementary approach to GWAS in this context. Also, liver tissue mRNA microarray analysis revealed higher gene expression levels in ULK4 in PBC patients (P < 0.01). Lastly, we estimated the common SNP heritability of PBC in the Japanese population (0.210 ± 0.026).
虽然十多年前全基因组关联研究(GWAS)的出现极大地推动了我们对复杂性状的理解,但单核苷酸多态性(SNP)分析的局限性也导致了几种其他方法的发展。模拟研究表明,区域遗传力映射(RHM)方法利用多个相邻 SNP 共同估计基因组给定区域的遗传效应,通常比单 SNP GWAS 具有更高的检测能力。然而,迄今为止,它的应用主要局限于农业领域,其在人类疾病中发现新基因的潜力尚未得到充分利用。在这项研究中,我们通过在日本人群中应用 RHM 方法研究原发性胆汁性胆管炎(PBC),在全基因组显著水平上鉴定了三个新的基因座(STAT4、ULK4 和 KCNH5),其中两个基因座(ULK4 和 KCNH5)以前在任何人群中都没有发现与 PBC 相关。值得注意的是,这些基因不能通过传统的单 SNP GWAS 检测到,这突出了 RHM 方法在检测人类疾病新易感基因座方面的潜力。这些发现为 RHM 是 GWAS 在这种情况下的有效且实用的补充方法提供了强有力的经验证据。此外,肝组织 mRNA 微阵列分析显示 PBC 患者 ULK4 的基因表达水平更高(P < 0.01)。最后,我们估计了日本人群中 PBC 的常见 SNP 遗传力(0.210 ± 0.026)。